Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 25.80
+0.15 (0.58%)
Sep 30, 2026, 1:30 PM CST
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.87 billion as of September 29, 2026. Its market cap has decreased by -14.64% in one year.
Market Cap
3.87B
Enterprise Value
2.68B
Revenue
52.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.80
ChartMarket Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.87B, a decrease of -30.03%. That is a compound annual growth rate of -6.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.87B | -2.84% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 4.69B |
| Mycenax Biotech | 4.69B |
| UnicoCell Biomed | 4.57B |
| Sinew Pharma | 4.29B |
| BRIM Biotechnology | 4.14B |
| Pharmosa Biopharm | 4.05B |
| Great Novel Therapeutics Biotech & Medicals | 3.68B |
| BioGend Therapeutics | 3.37B |